04/15/2025 6:01 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2025 6:44 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 424B3 | |
04/03/2025 11:15 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form EFFECT | |
03/27/2025 4:05 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form POS AM | |
03/27/2025 4:07 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2025 4:15 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/20/2025 6:31 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 7:30 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 7:30 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/02/2024 4:31 PM | Kim Hyung Heon (Reporting) MetaVia Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) MetaVia Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2024 8:10 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for NRBO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
11/18/2024 7:35 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2024 6:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 7:07 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 3:20 PM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2024 3:10 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 7:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form PRE 14A | |
07/30/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2024 11:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form EFFECT | |
07/24/2024 4:11 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
07/18/2024 7:21 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
07/16/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2024 10:11 AM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer)
| Form 4/A | |
06/26/2024 8:15 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 3:15 PM | DONG-A ST CO., LTD (Filed by) NeuroBo Pharmaceuticals, Inc. (Subject) NeuroBo Pharmaceuticals (Subject) NeuroBo Pharmaceuticals, Inc. (Subject)
| Form SC 13D/A | |
06/25/2024 3:16 PM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 7:21 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
06/25/2024 7:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/24/2024 5:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 6:24 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) Tursi James Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:24 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) STRICKLAND D GORDON (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:25 PM | Glickman Mark A (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:25 PM | KOVEN ANDREW I (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:26 PM | GROVES JASON L (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:26 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) Salsbury Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 8:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
BREAKING: Trump Bans NVIDIA Chips to China (Ad) On April 16th, 2025, President Trump banned Nvidia from selling its most advanced semiconductors to China.
That brings the U.S. and China closer to war than at any time since the Korean War ended in 1953. There's a good chance you own at least one of these through a brokerage account, mutual fund, 401K, |
05/09/2024 7:05 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2024 7:41 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
04/30/2024 7:42 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form ARS | |
04/30/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2024 11:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form EFFECT | |
04/17/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |